BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 24778216)

  • 1. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.
    Hsieh CL; Fei T; Chen Y; Li T; Gao Y; Wang X; Sun T; Sweeney CJ; Lee GS; Chen S; Balk SP; Liu XS; Brown M; Kantoff PW
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7319-24. PubMed ID: 24778216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long terminal repeats act as androgen-responsive enhancers for the PSA-kallikrein locus.
    Lawrence MG; Stephens CR; Need EF; Lai J; Buchanan G; Clements JA
    Endocrinology; 2012 Jul; 153(7):3199-210. PubMed ID: 22597536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
    Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.
    Andreu-Vieyra C; Lai J; Berman BP; Frenkel B; Jia L; Jones PA; Coetzee GA
    Mol Cell Biol; 2011 Dec; 31(23):4648-62. PubMed ID: 21969603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
    Liu Y; Liu Y; Yuan B; Yin L; Peng Y; Yu X; Zhou W; Gong Z; Liu J; He L; Li X
    Oncotarget; 2017 Mar; 8(10):17027-17037. PubMed ID: 28199985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.
    Jin F; Claessens F; Fondell JD
    J Biol Chem; 2012 Jan; 287(2):858-70. PubMed ID: 22102282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional roles of antisense enhancer RNA for promoting prostate cancer progression.
    Pan CW; Wen S; Chen L; Wei Y; Niu Y; Zhao Y
    Theranostics; 2021; 11(4):1780-1794. PubMed ID: 33408781
    [No Abstract]   [Full Text] [Related]  

  • 9. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
    Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription.
    Thompson J; Lepikhova T; Teixido-Travesa N; Whitehead MA; Palvimo JJ; Jänne OA
    EMBO J; 2006 Jun; 25(12):2757-67. PubMed ID: 16724108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.
    Nilsson EM; Laursen KB; Whitchurch J; McWilliam A; Ødum N; Persson JL; Heery DM; Gudas LJ; Mongan NP
    Oncotarget; 2015 Nov; 6(34):35710-25. PubMed ID: 26461474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.
    Shiota M; Yokomizo A; Tada Y; Inokuchi J; Tatsugami K; Kuroiwa K; Uchiumi T; Fujimoto N; Seki N; Naito S
    Mol Endocrinol; 2010 Jan; 24(1):114-27. PubMed ID: 19884383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
    Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
    EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.
    Wang D; Garcia-Bassets I; Benner C; Li W; Su X; Zhou Y; Qiu J; Liu W; Kaikkonen MU; Ohgi KA; Glass CK; Rosenfeld MG; Fu XD
    Nature; 2011 May; 474(7351):390-4. PubMed ID: 21572438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor.
    Powzaniuk M; McElwee-Witmer S; Vogel RL; Hayami T; Rutledge SJ; Chen F; Harada S; Schmidt A; Rodan GA; Freedman LP; Bai C
    Mol Endocrinol; 2004 Aug; 18(8):2011-23. PubMed ID: 15131260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation.
    Kim SJ; Choi H; Park SS; Chang C; Kim E
    Mol Cells; 2011 Apr; 31(4):371-7. PubMed ID: 21331774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
    Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
    Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
    Baumgart SJ; Nevedomskaya E; Lesche R; Newman R; Mumberg D; Haendler B
    Mol Oncol; 2020 Sep; 14(9):2022-2039. PubMed ID: 32333502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.